Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions
Generated Narrative: Ingredient
Resource Ingredient "d01421cc-6488-468b-a676-d3e7281875e2"
Profile: Drug Product Component
status: draft
role: Inactive Ingredient (Dummy NCIT Codesystem#C42637)
substance
Codes
Reference urn:uuid:393a14e7-3edc-4373-bbe5-9e569d504a1c Strengths
Extension Presentation[x] TextPresentation 700 mg (Details: http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy code C28253 = 'mg')/1 [arb'U] (Details: http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy code C75765 = '[arb'U]') 700mg